Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant Generics Limited (Jubilant), has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of Rs. 4,700 per vial of 100 mg (lyophilized injection). The Company will make the drug…
Jubilant Life Sciences to produce COVID-19 drug; Nanjangud plant still closed
May 13, 2020Mysore/Mysuru: Jubilant Life Sciences Limited, an India-based Pharmaceutical and Life Sciences Company, yesterday announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive licensing agreement with Gilead Sciences that will grant Jubilant the right to register, manufacture and sell Gilead’s investigational drug ‘Remdesivir’, a potential therapy for COVID-19 in 127 countries including India….
Managing COVID-19 crisis…: Jubilant Life Sciences Limited extends support to State Govt.
April 6, 2020Mysore/Mysuru: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has in a press release, said that it is providing support to the State Government in its effort to deliver effective health and safety services to manage COVID-19 crisis and has contributed a sum of Rs. 25 lakh towards the Chief Minister’s…
Recent Comments